Wicklow Capital Inc. 4
4 · MedMen Enterprises, Inc. · Filed Feb 1, 2021
Insider Transaction Report
Form 4
Wicklow Capital Inc.
10% Owner
Transactions
- Sale
Class B Subordinate Voting Shares
2021-01-28$0.20/sh−488,899$97,829→ 18,851,033 total(indirect: By Milestone. See footnote 4.) - Sale
Class B Subordinate Voting Shares
2021-01-29$0.20/sh−1,124,358$223,185→ 17,726,675 total(indirect: By Milestone. See footnote 4.)
Holdings
- 6,395,433(indirect: By Clarence, LP. See footnote 4.)
Class B Subordinate Voting Shares
- 22,353,472(indirect: By Clarence, LP. See footnote 4.)
Class B Subordinate Voting Shares
- 12,195,122(indirect: By Milestone. See footnote 4.)
Class B Subordinate Voting Shares
Footnotes (7)
- [F1]This Form 4 is being filed jointly by Wicklow Capital, Inc., an Illinois corporation ("Wicklow"), Milestone Investments, LP, an Alaska limited partnership ("Milestone"), the Dan Tierney & Daniel V. Tierney 2003 Trust (the "Trust"), and Daniel V. Tierney (collectively, the "Reporting Persons").
- [F2]The aggregate number of Class B Subordinate Voting Shares ("Class B Shares") of Issuer sold on the same day at different prices, which are reported herein in Canadian dollars ("CAN$").
- [F3]Represents the weighted average sales price. The Class B Shares were sold at prices ranging from CAN$0.20 to CAN$0.205 per share. Full information regarding the number of such shares sold at each price shall be provided to the Securities and Exchange Commission staff (the "Staff"), Issuer or any security holder, upon request.
- [F4]Wicklow is the general partner of each of Milestone and Clarence, LP ("Clarence"). The Trust is the sole stockholder of Wicklow and the sole limited partner of Milestone and Clarence. Daniel V. Tierney is the trustee and sole beneficiary of the Trust and has voting and/or dispositive power over the securities of Issuer held by Wicklow, Milestone and Clarence. As a result, Daniel V. Tierney and the Trust may be deemed to indirectly beneficially own the securities of Issuer held by Wicklow, Milestone and Clarence. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest, if any, therein.
- [F5]See footnote 1.
- [F6]See footnote 2.
- [F7]Represents the weighted average sales price. The Class B Shares were sold at prices ranging from CAN$0.195 to CAN$0.2012 per share. Full information regarding the number of such shares sold at each price shall be provided to the Staff, Issuer or any security holder, upon request.